News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>UBS: MTR CORPORATION 2025 Results Miss, Mainly Dented by Recurring Income; Rating Sell
MTR CORPORATION (00066.HK) announced its annual results for the year ended December 2025 last week, UBS published a research report saying. Of which, its underlying net profit amou...
Reset
Send
The window will close in 5 seconds
<Research>UBS: MTR CORPORATION 2025 Results Miss, Mainly Dented by Recurring Income; Rating Sell
Close
Recommend
11
Positive
16
Negative
7
 
 

MTR CORPORATION (00066.HK)  0.000 (0.000%)    Short selling $42.60M; Ratio 164.371%   announced its annual results for the year ended December 2025 last week, UBS published a research report saying. Of which, its underlying net profit amounted to $16.7 billion, down 4% YoY, in line with the broker's expectation. However, recurring EBITDA fell by 13% YoY, below UBS' forecast.

At the earnings conference, MTR CORPORATION stated that the South Island Line (West) and Pak Shek Kok Station are currently in the planning stage. Along with Northern Link Part 2, UBS expected the capital expenditure for these three new projects to be disclosed in 2H26. It is anticipated that the share price will react negatively to the missing recurring profit.

Related News BofAS Expects Hong Kong Property Developers to Be More Cautious on Price Increases; Most Developers' EPS Has Bottomed Out
Therefore, UBS rated MTR CORPORATION at Sell, with a target price of $24.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.